Together with the evidence presented here, this shows that there is a clear trend towards the association of non-steroidal immunosuppressive therapy and corticosteroids in the management of initial-onset VKH disease.
← all excerpts
Reappraisal of the management of Vogt-Koyanagi-Harada disease: sunset glow fundus is no more a fatality.
1
—
—